CURE TV®

With CURE TV®, you have access to a variety of informative and uplifting videos. You’ll find interviews with cancer experts, advocates, patients, caregivers, as well as highlights from our celebratory events showcasing interviews with award winners and celebrity speakers.

Ibrance Shows Promise in Patients with Brain Metastases Who Harbor a CDK Pathway Alteration

December 19th 2019

New findings show that Ibrance has the potential to help patients with brain metastases that harbor a CDK pathway alteration.

Education and Teamwork Are Key in the Treatment of MPNs

December 16th 2019

At the 2019 MPN Heroes® event Tammy Matuska, B.S.N., RN, known as the "lifeline to patients," was honored for her outstanding work for patients with MPN.

The Future of Novel Immunotherapy Combinations in Melanoma

December 9th 2019

The overall survival rate in patients with melanoma has increased exponentially in the past decade. But thanks to the use of combinations in the treatment of melanoma, the future looks even brighter, according to one expert from the Melanoma Institute Australia.

The Importance of Clinical Trials in Multiple Myeloma

December 7th 2019

As patients progress through therapy, it is important that oncologists not disregard the novel agents that are currently being investigated in clinical trials, according to Memorial Sloan Kettering Cancer Center’s Dr. Sham Mailankody.

Stomping Out the Smoking Stigma for Patients with Lung Cancer

December 5th 2019

When others assume that patients with lung cancer must have smoked to get the disease, this stigma can affect patient outcomes.

Looking Out for Side Effects in Immunotherapy Combination Treatment

December 5th 2019

Immunotherapy in combination with chemotherapy is becoming a popular treatment for patients with lung cancer, but patients need to understand the side effects.

CAR T-Cell Therapy for Patients with Lymphoma

December 4th 2019

An overview of the therapies available for patients with diffuse large B-cell lymphoma (DLBCL) and transformed follicular lymphoma.

Common Mutations Could Lead to Targeted Treatment for Patients with Brain Metastases

December 3rd 2019

While scientists have a limited understanding of how brain metastases genetically evolve from their primary tumor, research presented at the Society for Neuro-Oncology’s Annual Meeting may have identified a connection between genetic mutations and treatment options that could offer patients improved outcomes.

Utilizing Psychosocial Data to Help Patients with Lung Cancer

December 3rd 2019

There is plenty of scientific data about the physical challenges patients with cancer endure, but more is needed to address psychosocial issues.

Being Open About Mental Health Care During Cancer Treatment

November 14th 2019

To combat the stigma around mental health care for patients with lung cancer, survivor Nancy Cohen shares her own treatment story and why she feels it's important to include mental health care during cancer treatment.

New Targeted and Immunotherapy Options in Lung Cancer

November 12th 2019

Hossein Borghaei, DO, MS, of Fox Chase Cancer Center, discusses emerging treatment options for patients with lung cancer.

The Search for Biomarkers in Renal Cell Carcinoma

November 9th 2019

When asked about the future of renal cell carcinoma (RCC) treatment, one expert is hopeful about the current search, but notes that more work is needed to find a reliable biomarker for use in patients with the most common kind of kidney cancer.

Patient Concerns and Treatment Decisions Are Impacted by Disease Stage

October 15th 2019

When making treatment decisions in breast cancer, patient concerns about how each treatment will affect their daily life — and their disease stage — have an important role to play, according to Dr. Sara Hurvitz.

Efficacy and Safety Are Key Factors When Selecting Breast Cancer Treatment

October 9th 2019

The safety profile and effectiveness of each therapeutic option are both important considerations to keep in mind when clinicians and patients weigh their breast cancer treatment options, according to one expert.

Jevtana's Toxicity Profile Makes It a Good Option in Metastatic Prostate Cancer

October 9th 2019

When other therapies have failed, patients with metastatic prostate cancer who were treated with Jevtana (cabazitaxel) in the third-line setting experienced a toxicity profile similar to that of androgen-targeted therapies, making the chemotherapy agent a valid choice for some patients, according to results from the CARD trial.

Third-Line Jevtana Improves Progression-Free Survival in Prostate Cancer Subtype

October 7th 2019

"Sequential treatment in prostate cancer is really something that’s evolving over time," Dr. Daniel Petrylak said of the study findings presented at the European Society of Medical Oncology Congress 2019.

Novel Agents Are Changing the Prostate Cancer Treatment Landscape

October 4th 2019

The addition of novel agents in the prostate cancer treatment landscape could create a shift in the way patients with advanced disease are treated, said Dr. Daniel George.

Patients Play an Important Role in Cancer Treatment

October 3rd 2019

While it is the responsibility of the clinician to inform their patients of all options available, it is, in turn, vital for them to play a role in selecting the cancer treatment that’s right for them, according to Dr. Sara Hurvitz.

Older Patients With Mantle Cell Lymphoma Benefit Most From Individualized Treatment

September 13th 2019

While emerging therapies for mantle cell lymphoma (MCL) continue to shape the treatment landscape, no key standard currently exists, says one expert – particularly for older patients, who benefit most from a treatment approach that has been tailored to fit them and their disease.

MMRF Expert Offers Update on Multiple Myeloma Trials

September 4th 2019

The Multiple Myeloma Research Foundation is offering exciting new trials for patients with multiple myeloma – including the COMPASS and My Drug trials.

Investing in Every Patient: Katie Couric Shares Cancer Support and Resources

August 16th 2019

The legendary broadcast journalist Katie Couric sat down with CURE® to talk about founding the Jay Monahan Center for Gastrointestinal Health in honor of her late husband.

Katie Couric: 'If I Could Say Something to My Younger Self'

August 9th 2019

The legendary broadcast journalist Katie Couric opened up about what she wishes she’d known and wishes she could tell her younger self when her husband was first diagnosed with cancer.

Kerry Fraser Talks Cancer Treatment

August 7th 2019

During an interview with the “CURE Talks Cancer” podcast, retired NHL referee Kerry Fraser discussed what it is like going through treatment for essential thrombocythemia.

A Three-Time Cancer Survivor Finds a 'Ray of Light' and Opens Up About Her First Diagnosis

August 6th 2019

Three-time cancer survivor and “Pink Hulk” one-woman show writer and performer, Valerie David, recalls the day she learned she had non-Hodgkin lymphoma.

Katie Couric: Cancer Caregivers May Feel Alone, But You're Not

August 2nd 2019

The legendary broadcast journalist Katie Couric sat down with CURE® to discuss her advocacy work with Stand Up To Cancer and the “With Love, Me” campaign and why they are so special to her.

Kerry Fraser: Finding a 'New Normal' After a Cancer Diagnosis

July 30th 2019

Retired NHL referee Kerry Fraser explained how rest and exercise both factor into his “new normal” after receiving a diagnosis of essential thrombocythemia in 2017.

What Being a Survivor Means to 'The Pink Hulk', a Three-Time Cancer Survivor

July 29th 2019

Three-time cancer survivor and one-woman show writer and performer, Valerie David, sat down with CURE® to discuss life as a survivor.

Caregiver, Survivor and Advocate: Katie Couric

July 26th 2019

The legendary broadcast journalist Katie Couric sat down with CURE® to discuss her advocacy work in increasing cancer awareness with Stand Up To Cancer.

Kerry Fraser: Advice for Newly Diagnosed Patients with Cancer

July 24th 2019

Retired NHL referee Kerry Fraser shares his advice for coping with a new diagnosis after receiving his own in 2017.

Investigating Clinical Trials, Treatments and Facing Cancer Setbacks with Katie Couric

July 19th 2019

The legendary broadcast journalist Katie Couric sat down with CURE® to discuss the setbacks she and her husband faced when pursuing new treatment and clinical trials.